These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 20471487)

  • 1. Biomarkers in COPD.
    Cazzola M; Novelli G
    Pulm Pharmacol Ther; 2010 Dec; 23(6):493-500. PubMed ID: 20471487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary biomarkers in chronic obstructive pulmonary disease.
    Barnes PJ; Chowdhury B; Kharitonov SA; Magnussen H; Page CP; Postma D; Saetta M
    Am J Respir Crit Care Med; 2006 Jul; 174(1):6-14. PubMed ID: 16556692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical utility of biomarkers in asthma and COPD.
    Snell N; Newbold P
    Curr Opin Pharmacol; 2008 Jun; 8(3):222-35. PubMed ID: 18468485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers in COPD.
    Tzortzaki EG; Lambiri I; Vlachaki E; Siafakas NM
    Curr Med Chem; 2007; 14(9):1037-48. PubMed ID: 17439401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of cellular and biochemical markers of airway inflammation in patients with mild-to-moderate asthma and chronic obstructive pulmonary disease: an induced sputum and bronchoalveolar lavage fluid study.
    Gorska K; Krenke R; Domagala-Kulawik J; Korczynski P; Nejman-Gryz P; Kosciuch J; Hildebrand K; Chazan R
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():271-83. PubMed ID: 19218651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeatability of and relationship between potential COPD biomarkers in bronchoalveolar lavage, bronchial biopsies, serum, and induced sputum.
    Röpcke S; Holz O; Lauer G; Müller M; Rittinghausen S; Ernst P; Lahu G; Elmlinger M; Krug N; Hohlfeld JM
    PLoS One; 2012; 7(10):e46207. PubMed ID: 23056262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory markers for COPD in "susceptible" smokers.
    Tzortzaki EG; Tsoumakidou M; Makris D; Siafakas NM
    Clin Chim Acta; 2006 Feb; 364(1-2):124-38. PubMed ID: 16139829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid metabolite levels of prostaglandin D2 and eicosapentaenoic acid recovered from bronchoalveolar lavage fluid correlate with lung function of chronic obstructive pulmonary disease patients and controls.
    Csanky E; Rühl R; Scholtz B; Vasko A; Takacs L; Hempel WM
    Electrophoresis; 2009 Apr; 30(7):1228-34. PubMed ID: 19294692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomics-based biomarkers in chronic obstructive pulmonary disease.
    Chen H; Wang D; Bai C; Wang X
    J Proteome Res; 2010 Jun; 9(6):2798-808. PubMed ID: 20387909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in proteomic techniques for biomarker discovery in COPD.
    Casado B; Luisetti M; Iadarola P
    Expert Rev Clin Immunol; 2011 Jan; 7(1):111-23. PubMed ID: 21162654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Airway biomarkers in chronic obstructive pulmonary disease].
    Tohda Y; Higashimoto Y
    Nihon Rinsho; 2011 Oct; 69(10):1802-5. PubMed ID: 22073577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exhaled breath condensate analysis in chronic obstructive pulmonary disease.
    Chhabra SK; Gupta M
    Indian J Chest Dis Allied Sci; 2012; 54(1):27-37. PubMed ID: 22779120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum and bronchial lavage fluid concentrations of IL-8, SLPI, sCD14 and sICAM-1 in patients with COPD and asthma.
    Hollander C; Sitkauskiene B; Sakalauskas R; Westin U; Janciauskiene SM
    Respir Med; 2007 Sep; 101(9):1947-53. PubMed ID: 17574828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers in chronic obstructive pulmonary disease.
    Rosenberg SR; Kalhan R
    Transl Res; 2012 Apr; 159(4):228-37. PubMed ID: 22424427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exhaled breath condensate cytokine patterns in chronic obstructive pulmonary disease.
    Gessner C; Scheibe R; Wötzel M; Hammerschmidt S; Kuhn H; Engelmann L; Hoheisel G; Gillissen A; Sack U; Wirtz H
    Respir Med; 2005 Oct; 99(10):1229-40. PubMed ID: 16140223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarkers in obstructive respiratory diseases: an update.
    Braido F; Bagnasco D; Scichilone N; Santus P; Solidoro P; Di Marco F; Corsico A; Canonica GW
    Panminerva Med; 2012 Jun; 54(2):119-27. PubMed ID: 22525566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exhaled air molecular profiling in relation to inflammatory subtype and activity in COPD.
    Fens N; de Nijs SB; Peters S; Dekker T; Knobel HH; Vink TJ; Willard NP; Zwinderman AH; Krouwels FH; Janssen HG; Lutter R; Sterk PJ
    Eur Respir J; 2011 Dec; 38(6):1301-9. PubMed ID: 21700610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomics-based diagnosis of chronic obstructive pulmonary disease: the hunt for new markers.
    Casado B; Iadarola P; Luisetti M; Kussmann M
    Expert Rev Proteomics; 2008 Oct; 5(5):693-704. PubMed ID: 18937559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential prognostic value of biomarkers in lavage, sputum and serum in a five year clinical follow-up of smokers with and without COPD.
    Holz O; Waschki B; Roepcke S; Watz H; Lauer G; Faulenbach C; Hohlfeld JM
    BMC Pulm Med; 2014 Mar; 14():30. PubMed ID: 24581181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood specimen biomarkers of inflammation, matrix degradation, angiogenesis, and cardiac involvement: a future useful tool in assessing clinical outcomes of COPD patients in clinical practice?
    Kristan SS
    Arch Immunol Ther Exp (Warsz); 2013 Dec; 61(6):469-81. PubMed ID: 23703244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.